COVID-19 CURE? LOW-COST STEROID DEXAMETHASONE EMERGES AS LIFE-SAVING DRUG

Views : 328
Update time : 2022-09-06 13:56:23

Sinofin Pharmaceuticals has established itself as a top generic pharmaceutical company. With Dexamethasone is a type of corticosteroid medication manufactured by Sinofin  Pharmaceuticals China . It is used in the treatment of many conditions, including COVID-19 respiratory side effects, rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis.

Dexamethasone injection, Dexamethasone injection manufacturer in China , Generic Manufacturers exporters China , Dexamethasone injection Information from Drugs, China n Dexamethasone injection, wholesale Dexamethasone injection suppliers, Generic Medicines product, Dexamethasone injection Exporter, Generic pharmaceutical drugs Exporters, Exporters and Supplier, China n - Dexamethasone injection

In adrenocortical insufficiency, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone. In preterm labor, it may be used to improve outcomes in the baby. It may be taken by mouth, as an injection into a muscle, or intravenously. The effects of dexamethasone are frequently seen within a day and last for about three days.

 

The results highlight that administering low doses of the generic steroid dexamethasone to patients admitted to the hospital with COVID-19 yielded the aforementioned results.

 

Low-cost, anti-inflammatory drug dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19, according to a recent trial data.

 

The results of the UK-based RECOVERY trial, one of the world’s largest randomised trial of drugs to treat COVID-19 patients, were published on June 16. Being termed a “major breakthrough” by experts leading the trial, the results show that dexamethasone reduced deaths by one-third in ventilated patients and by one fifth in other patients receiving oxygen only.

 

Calling it a “groundbreaking development”, the UK Government’s Chief Scientific Adviser Sir Patrick Vallance said, “This is tremendous news today from the Recovery trial showing that dexamethasone is the first drug to reduce mortality from COVID-19. It is particularly exciting as this is an inexpensive widely available medicine.”

 

The results highlight that administering low doses of the generic steroid dexamethasone to patients admitted to the hospital with COVID-19 yielded the aforementioned results.

 

Peter Horby, one of the Chief Investigators for the trial and a professor at Oxford University said: “Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result. The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients. Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide.”

 

Since the appearance of COVID-19 six months ago, the search has been on for treatments that can improve survival, particularly in the sickest patients. These preliminary results from the RECOVERY trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications,” said Martin Landray, another Oxford University professor who is co-leading the trial.

 

There are currently no approved treatments or vaccines for COVID-19, the illness caused by the new coronavirus which has killed more than 431,000 globally.

 

Source: moneycontrol.com

 

Sinofin Pharmaceuticals as Manufacturer of Dexamethasone injection

 

Dexamethasone injection manufacturer in China {Sinofin Pharmaceuticals}; best quality supplier and exporter of Dexamethasone injection

 

Sinofin Pharmaceuticals manufactures a wide range of pharmaceuticals formulation involving Tablets / Capsules / Injections and Orals. Sinofin Pharma China team has an excellent expertise in export of Dexamethasone injection. Sinofin Pharmaceuticals places its main business as a Pharmaceuticals manufacturing and exports of generic drug supply of Dexamethasone injection; primarily of pharmaceuticals preparations known as Dexamethasone injection; as well as more than 100+ generic equivalent drug. Sinofin Pharmaceuticals has performed these business activities related to exports of Dexamethasone injection for major foreign-affiliated pharmaceutical import companies, ministry of health, tenders etc. and have enjoyed the full confidence of these companies, instructions and governments.

 

Sinofin Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Dexamethasone injection; at Sinofin Pharma we will appropriately meet diverse needs for Dexamethasone injection export manufacturing in a wide range of activities from investigation of possible formulations of Dexamethasone injection, formulation development, making applications to the international regulatory authorities for marketing approval, validation of Dexamethasone injection through to manufacturing scale production at our cGMP compliant manufacturing units.

 

We at Sinofin Pharma intend to make our manufacturing systems comply with the requirements of the FDA (cGMP) such that pilot plant scale production of products in the stage of clinical development or for use in clinical studies, as well as manufacture of products in small lots are practicable to ensure a highly stable pharmaceuticals formulations of generic equivalent and bio-similar products. We conduct extensive bio-similar and bio-equivalency studies for all our formations in order to obtain better shelf life, absorption and excellent quality of our generic formulation.

 

Sinofin Pharmaceuticals LICENCES & CERTIFICATES for Dexamethasone injection

 

GMP Certified

our supplier is manufactures Dexamethasone injection under GMP Plant.

ISO 9001: 201    

All infrastructure of Pharmaceuticals is ISO 9001:201 compliant and Sinofin Pharma team adheres to the specifies requirements for a quality management system in order to achieve : 1) To demonstrate our ability to consistently provide products and services that meet customer and applicable statutory and regulatory requirements, and. 2) Sinofin  Pharma aims to enhance customer satisfaction through the effective application of the system, including processes for improvement of the system and the assurance of conformity to customer and applicable statutory and regulatory requirements.

All manufacturing units of Sinofin Pharmaceutical follows the requirements of ISO 9001:201; which are generic under our standard operating procedure (SOP) and we intend such SOPs to be applicable to all manufacturing units, regardless of its type or size, or the products and services we provide.

 

Sinofin Pharma has excellent infrastructure and drug manufacturing technology to offer private label / third party brands and generics as well; Sinofin Pharma team invites you to approach us for providing you an option for your products giving your customized requirement from product name to formula; also in international packing and manufacturing standards with all regulatory document needs.

 

We are exporting our Dexamethasone injection product in Following Countries:

 

Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Sinofin ikistan, Turkmenistan, Uzbekistan and Ukraine

 

GCC/ Middle East Countries: Yemen

 

African Countries: Nigeria, Tanzania, Angola

 

Southeast Asia: Myanmar, Philippines

 

Dexamethasone injection Regulatory Documents:

 

Certificate of Analysis (COA)

Method of Analysis (MOA)

Stability Data (Accelerated stability / Long term stability / Zone)

CTD Dossier / ACTD Dossiers / eCTD Dossiers

Certificate of Pharmaceuticals Product (COPP)

Free Sale Certificate (FSC)

Leading Dexamethasone injection Manufacturers, Suppliers in China

 

Sinofin Pharmaceuticals, one of the leading Dexamethasone injection Manufacturers China brings the best-quality products.

 

 

When it comes to manufacturing any Dexamethasone injection, Sinofin Pharmaceutical always leads. The continuous efforts to become one of the best Dexamethasone injection manufacturers has made the company to bring the world-class standards – from research laboratories to maintenance. A wide range of life saving Drugs available at Sinofin Pharma. To manufacture excellent quality Dexamethasone injection we use high-standard equipment, with the latest technology. Our standard drugs satisfy most of the our customers.

 

Third Party Manufacturer of Dexamethasone injection

 

Sinofin Pharmaceuticals is popular for manufacturing a lot of pharmaceutical and medical products along with Dexamethasone injection. Sinofin Pharma is very famous for its competitive price range as well which are nicely suitable for a common man.

 

Sharing the safest methods and providing the safest product to the customer and client is our first purity and duty as well. Sinofin Pharma’s keen focus that we provide safety to consume Dexamethasone injection to our customer along with that we also take care of our workers and all the professionals who are implementing the tasks of manufacturing these injections. Sinofin Pharmaceuticals has a few manufacturing units and plants in China where all the processes go through under the keen guidance of experts by which create more chances of production of a perfect product with present accuracy. Sinofin Pharmaceuticals continues its participation in every pharmaceutical event ensures us that we can be able to polish and update our firm.

 

Contract Manufacturing

Manufacturing Unit

 

Built up area of approx. 100,000 sq. ft with separate areas for production, stores & non process blocks.

Engineering, Utilities to commensurate production facility

Designed and built as per vertical flow concept of man – material movement

Highly skilled and experienced technical staff

Immaculate environmental monitoring, calibration and validation programme

c-GMP compliant with latest manufacturing equipments

Dedicated & modular laboratories with latest sophisticated instruments as per GLP norms

Automated access control system and fully equipped cameras

Separate entry and exit for man, material and service personnel for both process blocks

In house water & sewerage treatment plant.

Online Order Tracking

In order to solve the major problem faced by many pharmaceuticals clients is they are always in a state of dilemma that when their product will be dispatched. They are not able to track the lifecycle of product in a transparent manner which causes loss of trust and commitment. Sinofin  Pharmaceuticals has developed a fully automatic online solution which helps you to immediately determine the production stage of products at any given time. Here are the few stages which you can see:

 

Design Approved

Carton/ Foil Received

Raw Material Ok & Batch Planned

Batch Processed

Testing Done

Packing Done

Dispatched from Plant

Tracking No.

100% Transparent Process

 

In order to give you full confidence over the quality of product we provide you with many resources such as:

 

COA (Certificate of Analysis)

Raw Material Procurement Certificate

Batch Inspection Report

With the sufficient proofs in your hand it becomes easy to convince others about the quality of your products.

 

 

GMP Certified

 

At Sinofin Pharmaceuticals, we use state-of-the-art technology, the most stringent operating procedures and we have earned a name for ourselves for maintaining the highest standards of quality.

Want to get your products Manufactured by Sinofin Pharma?

 

We at Sinofin Pharmaceuticals would be happy to help you. Just send your details below and we will take care of everything.